down arrow

Concord Biotech

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,660.00
59.35 (3.71%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 68.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidated - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
Share Capital
10.46
10.46
9.51
9.51
Share Warrants & Outstandings
Total Reserve
1,516.18
1,279.54
1,093.71
760.72
Shareholder's Funds
1,526.65
1,290.00
1,103.22
770.23
Minority Interest
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
6.24
31.25
35.53
Secured Loans
0.00
6.24
31.25
35.53
Unsecured Loans
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
28.06
23.44
20.97
15.13
Other Long Term Liabilities
1.887
0.1638
0.310700000000003
2.9345
Long Term Trade Payables
0.00
0.00
0.00
0.00
Long Term Provisions
1.96
2.30
1.87
1.59
Total Non-Current Liabilities
31.91
32.13
54.40
55.19
Current Liabilities
Trade Payables
94.44
93.80
83.11
71.44
Other Current Liabilities
37.59
45.57
40.98
43.58
Short Term Borrowings
6.23
25.00
29.34
0.00
Short Term Provisions
3.90
27.48
1.75
0.28
Total Current Liabilities
142.16
191.84
155.17
115.31
Total Liabilities
1,700.71
1,513.98
1,312.79
940.73
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
Gross Block
822.25
791.43
717.48
306.96
Less: Accumulated Depreciation
250.20
198.71
145.87
70.55
Less : Impairment of Assets
0.00
0.00
0.00
0.00
Net Block
572.05
592.72
571.61
236.41
Lease Adjustment
0.00
0.00
0.00
0.00
Capital Work in Progress
211.48
172.70
74.16
141.40
Intangible assets under development
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
Non Current Investments
2.06
0.12
0.26
0.81
Long Term Loans & Advances
12.87
11.84
31.30
15.15
Other Non Current Assets
2.75
8.64
1.44
4.96
Total Non-Current Assets
804.48
786.28
680.13
401.93
Current Assets Loans & Advances
Current Investments
243.70
136.93
73.47
198.11
Inventories
207.95
212.31
195.12
111.23
Sundry Debtors
349.61
273.76
232.17
183.50
Cash and Bank
47.02
43.45
88.93
2.59
Other Current Assets
25.34
43.59
13.96
14.51
Short Term Loans and Advances
22.60
17.66
29.01
28.86
Total Current Assets
896.23
727.70
632.67
538.79
Net Current Assets (Including Current Investments)
754.08
535.86
477.50
423.49
Total Current Assets Excluding Current Investments
652.53
590.77
559.19
340.69
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
Total Assets
1,700.71
1,513.98
1,312.79
940.73
Contingent Liabilities
14.31
14.31
13.32
3.89
Total Debt
6.23
31.24
60.59
35.53
Book Value per share (adjusted)
145.93
123.31
105.453636363636
73.6245454545455
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2024 is -80.06% vs -48.44% in Mar 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2024 is 1,081.25% vs -48.39% in Mar 2023

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2024 is 2.37% vs 18.53% in Mar 2023

stock-summary

Investments

YoY Growth in year ended Mar 2024 is 1,616.67% vs -53.85% in Mar 2023

stock-summary

Current Assets

YoY Growth in year ended Mar 2024 is 23.16% vs 15.02% in Mar 2023

Compare Balance Sheet Results of Concord Biotech
Markets Mojo
Figures in Rs cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.46
40.06
-29.60
-73.89%
Share Warrants & Outstandings
Total Reserve
1,516.18
9,299.78
-7,783.60
-83.70%
Shareholder's Funds
1,526.65
9,363.09
-7,836.44
-83.70%
Minority Interest
0.00
212.70
-212.70
-100.00%
Long-Term Borrowings
0.00
24.87
-24.87
-100.00%
Secured Loans
0.00
24.87
-24.87
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
28.06
8.67
19.39
223.64%
Other Long Term Liabilities
1.89
30.68
-28.79
-93.84%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.96
123.12
-121.16
-98.41%
Total Non-Current Liabilities
31.91
187.34
-155.43
-82.97%
Current Liabilities
Trade Payables
94.44
1,102.99
-1,008.55
-91.44%
Other Current Liabilities
37.59
456.26
-418.67
-91.76%
Short Term Borrowings
6.23
171.17
-164.94
-96.36%
Short Term Provisions
3.90
389.31
-385.41
-99.00%
Total Current Liabilities
142.16
2,119.73
-1,977.57
-93.29%
Total Liabilities
1,700.71
11,882.86
-10,182.15
-85.69%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
822.25
5,775.71
-4,953.46
-85.76%
Less: Accumulated Depreciation
250.20
1,354.82
-1,104.62
-81.53%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
572.05
4,420.89
-3,848.84
-87.06%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
211.48
207.09
4.39
2.12%
Intangible assets under development
0.00
74.70
-74.70
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.06
315.12
-313.06
-99.35%
Long Term Loans & Advances
12.87
163.97
-151.10
-92.15%
Other Non Current Assets
2.75
13.79
-11.04
-80.06%
Total Non-Current Assets
804.48
5,314.63
-4,510.15
-84.86%
Current Assets Loans & Advances
Current Investments
243.70
2,258.11
-2,014.41
-89.21%
Inventories
207.95
1,553.46
-1,345.51
-86.61%
Sundry Debtors
349.61
848.28
-498.67
-58.79%
Cash and Bank
47.02
1,197.97
-1,150.95
-96.08%
Other Current Assets
25.34
106.80
-81.46
-76.27%
Short Term Loans and Advances
22.60
610.77
-588.17
-96.30%
Total Current Assets
896.23
6,568.23
-5,672.00
-86.36%
Net Current Assets (Including Current Investments)
754.08
4,448.50
-3,694.42
-83.05%
Total Current Assets Excluding Current Investments
652.53
4,310.11
-3,657.58
-84.86%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,700.71
11,882.86
-10,182.15
-85.69%
Contingent Liabilities
14.31
116.23
-101.92
-87.69%
Total Debt
6.23
196.04
-189.81
-96.82%
Book Value per share (adjusted)
145.93
233.73
-87.80
-37.56%
Annual - Borrowings
Borrowings 6.23 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -80.06% vs -48.44% in Mar 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.89 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 1,081.25% vs -48.39% in Mar 2023

Annual - Fixed Assets
Fixed Assets 783.53 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 2.37% vs 18.53% in Mar 2023

Annual - Investments
Investments 2.06 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 1,616.67% vs -53.85% in Mar 2023

Annual - Current Assets
Current Assets 896.23 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 23.16% vs 15.02% in Mar 2023